Company: RNAC
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001453687-25-000060
Chunk: 31

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 15
Chunk 31
---
 the Registrant and Swedish Orphan Biovitrum AB (Publ)10-Q001-377984.18/6/20204.4Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ), as amended on November 4, 202010-Q001-377984.211/5/20204.5Form of Warrant to Purchase Stock, dated August 31, 2020, issued by Selecta Biosciences, Inc. to Oxford Finance LLC and Silicon Valley Bank, together with a schedule of warrants.8-K001-377984.19/3/20204.6Form of Common Stock Purchase Warrant, dated April 11, 20228-K001-377984.14/6/20224.7Form of Contingent Value Rights Agreement8-K001-377982.111/13/20234.8Registration Rights Agreement, by and among Selecta Biosciences, Inc. and certain purchasers party thereto8-K001-3779810.211/13/20234.9(a)Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock8-K001-377983.411/13/2023

72

Table of Contents

4.9(b)Certificate of Amendment to the Certificate of Designation of Series A Non-Voting Convertible Preferred Stock, dated March 26, 2024.8-K001-377983.13/28/20244.10Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock8-K001-377983.17/2/20244.11Form of Registration Rights Agreement, dated as of July 2, 2024, by and among the Registrant and the Investors named therein.8-K001-3779810.27/2/20244.12Description of Securities———Filed herewith10.1#Amended and Restated 2016 Incentive Award Plan and form of award agreements thereunderS-1333-28120410.18/2/202410.2#2016 Employee Stock Purchase PlanS-1/A333-21155510.36/8/201610.3#Amended and Restated Cartesian Therapeutics, Inc. 2018 Employment Inducement Incentive Award Plan, and forms of award agreements